Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1986-11-07
1989-04-18
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514573, 514913, A61K 31215, A61K 3119, A61K 31557
Patent
active
048228192
ABSTRACT:
Disclosed is the use of trimoprostil, and its derivatives, such as, 15-acetyl trimoprostil and pharmaceutically acceptable salts and esters thereof in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising trimoprostil and its derivatives.
REFERENCES:
patent: 4004027 (1977-01-01), Lippmann et al.
patent: 4029681 (1977-06-01), Smith
patent: 4070482 (1978-01-01), Lippmann et al.
patent: 4097496 (1978-06-01), Babej et al.
patent: 4112225 (1978-09-01), Holland et al.
patent: 4288616 (1981-09-01), Sih
patent: 4311707 (1982-01-01), Bimbaum et al.
patent: 4564637 (1986-01-01), Schachar
patent: 4599353 (1986-07-01), Bito
Chemistry, Biochemistry & Pharmacological Activity of Prostanoids-pp. 1, & 4-1978-Gorton.
Chem. Abst. 71:120112(a) (1969)-Beitch et al.
Chem. Abst. 78:80097(k) (1973)-Nakano et al.
Chem. Abst. 80:44231(g) (1974)-Chiang.
Chem. Abst. 81:21424(d) (1974)-Chiang.
Chem. Abst. 81:45653(d) (1974)-Masuda et al.
Chem. Abst. 102:161111(b) (1985)-Trzeciakowski et al.
DeSantis Louis M.
Sallee Verney L.
Alcon Laboratories Inc.
Arno James A.
Brown Gregg C.
Robinson Douglas W.
LandOfFree
Use of trimoprostil and derivatives in glaucoma therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of trimoprostil and derivatives in glaucoma therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of trimoprostil and derivatives in glaucoma therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397246